More than a million people who have both type 2 diabetes and kidney disease could benefit from a daily pill, finerenone, that slashes the risk of kidney failure, heart complications and death.
Maintaining treatment with a renin-angiotensin system inhibitor in people with advanced, progressive chronic kidney disease caused no problems compared with stopping it in a randomized study.